Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients
CompletedNCT03360682
Fundacion Clinic per a la Recerca BiomédicaHIV-1-infection, Solid Organ Transplant
Start: 2018-04-13End: 2020-05-21Updated: 2025-09-30